Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma.

@article{Xu2014RoleOL,
  title={Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma.},
  author={Xiaojing Xu and Peixin Huang and Hui xin Tian and Yi Chen and Ningling Ge and Wenqing Tang and Biwei Yang and Jinglin Xia},
  journal={Journal of gastroenterology and hepatology},
  year={2014},
  volume={29 6},
  pages={1273-8}
}
BACKGROUND AND AIM The purpose of the present study was to determine whether lamivudine in combination with transarterial chemoembolization (TACE) could reduce hepatitis B virus (HBV) activation and improve the survival of patients with hepatocellular carcinoma (HCC). METHODS From July 2008 to October 2011, a total of 181 consecutive HBV-related HCC patients undergoing TACE were randomized to two groups (92: lamivudine, 89: control). Follow up was every 3 months. Primary and secondary end… CONTINUE READING